Michael S. Wyzga - 17 Jun 2024 Form 4 Insider Report for Mereo BioPharma Group plc (MREO)

Role
Director
Signature
/s/ Christine Fox, by power of attorney
Issuer symbol
MREO
Transactions as of
17 Jun 2024
Net transactions value
+$99,950
Form type
4
Filing time
17 Jun 2024, 16:15:04 UTC
Previous filing
11 Jun 2024
Next filing
06 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MREO American Depositary Shares representing Ordinary Shares Award $99,950 +25,050 $3.99 25,050 17 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.